ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 46401 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 46401; 2) Community: the network communities that were significantly associated with the response to NSC 46401; 3) Molecule: the relationships between components within communities and NSC 46401; 4) MDR: the compounds that were significantly associated with the NSC 46401.

NSC Compound Enrichment Correlation
NSC 180973 Tamoxifen citrate 0.00479683626511392 0.0041940509
NSC 113943 6-Bromosangivamycin 0.00645628049634952 -0.1046946
NSC 146268 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- 0.00645628049634952 -0.15052942
NSC 201459 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- 0.00645628049634952 -0.35466253
NSC 335753 HELIANGOLIDE 0.00645628049634952 -0.12033443
NSC 625507 Null 0.00645628049634956 -0.20525098
NSC 626880 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-hydroxy- phenyl)methylene]-, hydrochloride 0.00645628049634956 -0.1295773
NSC 633041 Null 0.00645628049634956 -0.35417155
NSC 634472 Null 0.00645628049634956 -0.23313009
NSC 636918 Null 0.00645628049634956 -0.23617774
Total:101  Current:18    [First] [Prev] [Next] [Last]